- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
PaxMedica is a biotechnology business based in the US. PaxMedica shares (PXMD) are listed on the PINK and all prices are listed in US Dollars. Its last market close was $0.08 – an increase of 11% over the previous week. PaxMedica employs 6 staff and has a market cap (total outstanding shares value) of 0.00.
Our top picks for where to buy PaxMedica IncCommon Stock stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy PaxMedica stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – PXMD. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy PaxMedica stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
PaxMedica stock price (PINK: PXMD)
Use our graph to track the performance of PXMD stocks over time.PaxMedica shares at a glance
Information last updated 2024-11-21.
| Latest market close | $0.08 |
|---|---|
| 52-week range | $0.06 - $1.19 |
| 50-day moving average | $0.11 |
| 200-day moving average | $0.32 |
| Wall St. target price | $3.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-2.77 |
PaxMedica price performance over time
Historical closes compared with the close of $0.074 from 2024-12-19
| 1 week (2024-12-13) | 5.71% |
|---|---|
| 1 month (2024-11-21) | 5.71% |
| 3 months (2024-09-20) | -22.76% |
| 6 months (2024-06-21) | -66.52% |
| 1 year (2023-12-21) | -90.81% |
|---|---|
| 2 years (2022-12-21) | -99.70% |
| 3 years (2021-12-17) | N/A |
| 5 years (2019-12-17) | N/A |
PaxMedica financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -324.69% |
| Return on equity TTM | -7716.49% |
| Profit margin | 0% |
| Book value | $-0.23 |
| Market Capitalization | $1.1 million |
TTM: trailing 12 months
PaxMedica share dividends
We're not expecting PaxMedica to pay a dividend over the next 12 months.
Have PaxMedica's shares ever split?
PaxMedica's shares were split on a 1:17 basis on 30 October 2023 . So if you had owned 17 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your PaxMedica shares – just the quantity. However, indirectly, the new 1600% higher share price could have impacted the market appetite for PaxMedica shares which in turn could have impacted PaxMedica's share price.
PaxMedica share price volatility
Over the last 12 months, PaxMedica's shares have ranged in value from as little as $0.055 up to $1.19. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (PINK average) beta is 1, while PaxMedica's is -0.609. This would suggest that PaxMedica's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, PaxMedica has bucked the trend.
PaxMedica overview
PaxMedica, Inc. , a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. Its lead product candidate is PAX-101 that is in Phase 3 clinical trials, an intravenous formulation of suramin for the treatment of autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, fragile X syndrome, human African trypanosomiasis (HAT), and fragile X-associated tremor/ataxia syndrome. The company is developing PAX-102, an intranasal formulation of suramin for neurologic indications, as well as other new chemical entities that are targeted and selective antagonists of purine receptor subtypes; and PAX-HAT-301 for the treatment of HAT. It has a research collaboration agreement with PolarMar Health for Phase II clinical trial in austism spectrum disorder for emodin, which retains the rights for PolarMar to develop and commercialize any non-prescription supplement form of the product, and for PaxMedica, Inc. to retain exclusive rights to develop and commercialize a highly purified form of emodin. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc.
Frequently asked questions
What percentage of PaxMedica is owned by insiders?Currently 9.007% of PaxMedica shares are held by insiders. How many people work for PaxMedica?
Latest data suggests 6 work at PaxMedica. When does the fiscal year end for PaxMedica?
PaxMedica's fiscal year ends in December. Where is PaxMedica based?
PaxMedica's address is: 303 South Broadway, Tarrytown, NY, United States, 10591 What is PaxMedica's ISIN number?
PaxMedica's international securities identification number is: US70424C1045
More resources on Finder
More guides on Finder
-
How to buy Merck-and-Company stock (MRK)
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Intuitive Surgical stock (ISRG)
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
-
How to buy Vertex Pharmaceuticals stock (VRTX)
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
-
How to buy McKesson Corporation stock (MCK)
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Amgen stock (AMGN)
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
-
How to buy Abbott Laboratories stock (ABT)
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question